After graduating from University of Bologna, Claudia joined Dr. Bruno Amati’s group at the European Institute of Oncology in Milan for her PhD studies. There, she investigated the transcriptional programs induced by p53 in suppressing cancer development and in response to DNA damage. Claudia joined the laboratory of Prof. David Tuveson to study the role of the redox master regulator Nrf2 in pancreatic cancer development and progression, with the ultimate goal of identifying new therapeutic targets for this deadly disease.